Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (851)
- Medicine suspension (506)
- Complementary medicine cancellation (205)
- Medical device suspension (87)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (55)
- Medical device cancellation - certain devices within an entry (23)
- Voluntary revocation at the request of the manufacturer (18)
- Registered medicine cancellation (14)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (4)
- Listed medicine cancellation (4)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (3)
- Revoked medicine suspension (2)
- AFT Pharmaceuticals Pty Ltd (1)
- Alphapharm Pty Ltd (1)
- Complementary Medicine Cancellation (1)
- Complementary medicine cancellation (1)
- Medical device cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Search
1889 result(s) found, displaying 276 to 300
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionWe have cancelled Sphygmomanometer, mercury under subsection 41GM(1) of the Act
-
Cancellation or suspensionWe have cancelled Sphygmomanometer, mercury under subsection 41GM(1) of the Act
-
Cancellation or suspensionWe have cancelled Thermometer, capillary, mercury under subsection 41GM(1) of the Act
-
Cancellation or suspensionWe have cancelled Foetal Doppler system under subsection 41GN(1) of the Act
-
Cancellation or suspensionWe have cancelled Foetal Doppler system Model: JPD 100S mini, JPD 100S6+, JPD 100S9 under subsection 41GN(1) of the Act
-
Cancellation or suspensionRegulatory action due to incorrect certification under paragraph 26A(2)(a) of the Act (paragraph 30(1)(e) of the Act), the medicine is not eligible for listing, in accordance with paragraph 30(1A)(a) of the Act.
-
Cancellation or suspensionWe have cancelled the medicine Hangover Relief 304293, from the Australian Register of Therapeutic Goods (ARTG) under 30(2) of the Therapeutic Goods Act 1989. Effective 24/1/24.
-
Cancellation or suspensionWe have cancelled the Radio-frequency probe cannula from the Australian Register of Therapeutic Goods (ARTG), under section 41GM of the Therapeutic Goods Act 1989.
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionUnder subsection 41GA(1)(a) there is a potential risk of death, serious illness or serious injury if the kind of device continues to be included in the Register, effective 21/12/2023
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionUnder subsection 41GA(1)(a) there is a potential risk of death, serious illness or serious injury if the kind of device continues to be included in the Register, effective 21/12/2023
-
Cancellation or suspensionSuspension from the ARTG under paragraph 41GA(1)(a)
-
Cancellation or suspensionUnder subsection 41GA(1)(a) there is a potential risk of death, serious illness or serious injury if the kind of device continues to be included in the Register, effective 21/12/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/12/2023
Last updated